Biliary complications following orthotopic liver transplantation: a 10-year audit  by Gunawansa, Nalaka et al.
ORIGINAL ARTICLE
Biliary complications following orthotopic liver transplantation:
a 10-year audit
Nalaka Gunawansa1, John L. McCall2, Andrew Holden3, Lindsay Plank4 & Stephen R. Munn4,5
1National Hospital of Sri Lanka and New Zealand Liver Transplant Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka, 2Department of Surgery, Faculty
of Medicine, University of Otago, Dunedin, New Zealand, 3Department of Radiology, Auckland City Hospital, Auckland, New Zealand, 4Department of
Surgery, Faculty of Medicine, University of Auckland, Auckland, New Zealand and 5Department of Surgery, Auckland District Health Board, Auckland,
New Zealand
Abstracthpb_300 391..399
Background: Biliary complications following liver transplantation result in major morbidity. We under-
took a 10-year audit of the incidence, management and outcomes of post-transplant biliary complications
at the New Zealand Liver Transplant Unit.
Methods: Prospectively collected data on 348 consecutive liver transplants performed between
February 1998 and October 2008 were reviewed. The minimum follow-up was 6 months.
Results: A total of 309 adult and 39 paediatric transplants were performed over the study period. Of
these, 296 (85%) were whole liver grafts and 52 (15%) were partial liver grafts (24 split-liver, eight
reduced-size and 20 live-donor grafts). There were 80 biliary complications, which included 63 (18%)
strictures and 17 (5%) bile leaks. Partial graft, a paediatric recipient and a Roux-en-Y biliary anastomosis
were independent predictors of biliary strictures. Twenty-five (40%) strictures were successfully managed
non-operatively and 38 (60%) required surgery (31 biliary reconstructions, three segmental resections and
four retransplants). Seven (41%) bile leaks required surgical revision and 10 (59%) were managed
non-operatively. There was no mortality related directly to biliary complications.
Conclusions: Biliary complications affected one in five transplant recipients. Paediatric status, partial
graft and Roux-en-Y anastomosis were independently associated with the occurrence of biliary strictures.
Over half of the affected patients required surgical revision, but no mortality resulted from biliary
complications.
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Introduction
Biliary complications following orthotopic liver transplantation
(OLT) remain a common problem despite advances in organ
procurement, preservation and surgical technique. Reported inci-
dences of post-transplant biliary complications are around
10–25%1–3 and such complications result in significant patient
morbidity and occasional graft loss. The incidence of biliary com-
plications has also been influenced by the increased use of partial
liver (PL) grafts, which include reduced-size grafts, split-liver
grafts and live-donor grafts.
The New Zealand Liver Transplant Unit (NZLTU) was initiated
in February 1998 with adult recipients, using only whole liver
(WL) grafts. The first paediatric recipient was transplanted in
2002, since when paediatric transplants have represented an
average of six to eight of the 36–40 OLTs carried out per annum.
Until May 2009, all WL grafts are sourced from donors after brain
death and do not include any organs donated after cardiac death.
This paper was presented at the 2009 Annual Meeting of the Transplant
Society of Australia and New Zealand, 17–19 June 2009, Canberra,
Australia.
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The first PL transplant was performed in 2002, as was the first
transplant from a live donor. There has since been a steady
increase in the use of PL grafts in both paediatric and adult recipi-
ents. The protocol for allograft preservation has also changed
twice during this 10-year period.
The purpose of this study was to review the first 10 years of OLT
at the NZLTU to identify the incidence, associated risk factors,
management and outcomes of post-OLT biliary complications.
Materials and methods
A prospective database of all patients undergoing transplantation
at the NZLTU has been maintained. The current study is based on
an analysis of these prospectively collected data, supplemented by
inpatient and outpatient clinical records and subsidiary databases
of radiological and endoscopic interventions performed in OLT
recipients.
A biliary stricture was defined as any narrowing in the bile ducts
identified on post-transplant imaging that was associated with
graft dysfunction and required intervention by radiological,
endoscopic or surgical means. The indications for imaging were
graft dysfunction detected by elevated serum transaminases,
clinical evidence of sepsis or features of biliary stasis on allograft
biopsy. Routine cholangiography was not performed. Imaging of
the biliary tree was performed using either magnetic resonance
cholangiopancreatography (MRCP) or endoscopic retrograde
cholangiopancreatography (ERCP). Percutaneous transhepatic
cholangiography (PTC) was performed if ERCP either failed
or was not possible as a result of a Roux-en-Y (ReY) biliary
anastomosis.
Three different organ preservation techniques were used during
the 10-year study period. From February 1998 to June 2002, Uni-
versity of Wisconsin perfusion fluid (UWS) was infused in situ
under gravitational pressure. From July 2002 to August 2007, an
additional 500 mL of UWS was infused under arterial pressure
perfusion (APP) on the back-table (UWS + APP). From Septem-
ber 2007 to October 2008, a low-viscosity perfusion fluid, histi-
dine tryptophan ketaglutarate (HTK), was infused in situ under
gravitational pressure without the addition of back-table APP.
The preferred technique for bile duct reconstruction was duct-
to-duct choledocho-choledochostomy (D–D) below the donor
cystic duct, using interrupted sutures. A stent or T-tube was not
used. In most paediatric recipients, in retransplants and in recipi-
ents with primary sclerosing cholangitis (PSC), an ReY was per-
formed using the same anastomotic technique. Post-transplant
immunosuppression was standardized with prednisone and tac-
rolimus combination in the majority of patients, while those with
pre-OLT renal dysfunction were managed with prednisone and
i.v. dacluzimab or basiliximab induction along with mycophe-
nalate mofetil and delayed introduction of low-dose tacrolimus.
Patient and donor variables included in the analysis were:
recipient age (paediatric <14 years, adult 14 years); donor age
(<50 years, 50 years); type of graft (WL, PL); cold ischaemia
time (CIT; <10 h, 10 h); warm ischaemia time (WIT; <45 min,
45 min); graft preservation solution and technique (UWS, UWS
+ APP, HTK); type of biliary anastomosis (D–D, ReY), and asso-
ciated presence or absence of hepatic artery stenosis (HAS) or
thrombosis (HAT).
Initially, biliary strictures were managed with endoscopic or
radiological dilatation and stenting. Endoscopic therapy was
always used as the preferred mode of non-operative treatment,
with balloon cholangioplasty and stenting. Covered stents and,
more recently, multiple stenting were used for anastomotic
strictures (AS), whereas uncovered stents were used in non-
anastomotic strictures (NAS) involving the intrahepatic biliary
tree. Percutaneous radiological therapy using standard pigtail
stents was reserved for those with an ReY, failure of endoscopic
therapy or for isolated intrahepatic NAS. A combination of
endoscopic and radiological techniques was used for inserting
internal–external stents in complex strictures. Choledochoscopy
was not used routinely in the management of these strictures.
Repeat imaging, dilatation and stenting were undertaken at inter-
vals of approximately 6 weeks or earlier if there was clinical or
biochemical evidence of stent blockage. This process was contin-
ued until the stricture had either resolved completely or the treat-
ment was deemed to have failed (generally after 4–6 months of
non-operative therapy), at which point surgical revision of the
biliary anastomosis was offered. In the presence of severe NAS
limited to one area of the allograft, segmental liver resection was
performed when non-operative approaches were unsuccessful.
Retransplantation was considered when all non-operative and
operative treatment options had been exhausted.
The data were entered into an electronic database and
statistical analysis carried out using sas Version 9.1 (SAS
Institute, Inc., Cary, NC, USA). Descriptive statistics have been
used to characterize the study population. Variables such as WIT
and CIT have been categorized and used as categorical variables
in order to facilitate a comparison between our findings and
results reported in the literature. Univariate and multivariate
logistic regression analyses were performed to identify factors
associated with the presence of biliary strictures. For these
analyses, recipient age, donor age and ischaemic times were
dichotomized.
Results
During the study period, 348 consecutive OLTs were performed in
338 recipients. A total of 38 (11%) recipients died during follow-
up, including three inpatients (inpatient mortality 0.8%). The
causes of the three inpatient deaths were massive stroke (post-
OLT day 16), pneumonia-induced septicaemia (post-OLT day 5)
and HAT (post-OLT day 4). Of the remaining 35 deaths, none
were a direct result of biliary complications and follow-up was
complete until the time of death. Follow-up of all remaining 310
recipients was complete to February 2009; the median length of
follow-up was 69 months (range: 6–132 months).
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Recipients included 309 (89%) adult and 39 (11%) paediatric
patients. Of the transplant recipients, 296 (85%) recipients,
including seven paediatric patients, received WL grafts and the
remaining 52 (15%) received PL grafts. The PL grafts comprised
24 split-liver grafts, eight reduced-size grafts and 20 live-donor
grafts. Demographic details of the recipient population, donor
population and transplant procedures are shown in Table 1.
There were 80 biliary complications in 70 recipients (overall
biliary complication rate 20%). These included 17 (5%) bile leaks
and 63 (18%) biliary strictures (ten patients had both leak and
stricture). Breakdowns and outcomes of the bile leaks and biliary
strictures are shown in Figs 1 and 2, respectively. Bile leaks
were diagnosed at a median of 17 days (range: 1–31 days) post-
transplant. Eight of the 11 (73%) anastomotic leaks progressed to
strictures despite treatment and were managed according to
the protocol for biliary strictures. Two such AS following bile
leaks progressed despite endoscopic stenting and were managed
by biliary reconstruction. The remaining six strictures were
successfully managed by endoscopic stenting.
Of the 63 patients who developed bile duct strictures, 46 (73%)
had AS, nine (14%) had NAS and eight (13%) had mixed stric-
tures (AS + NAS). The median time to presentation was 121 days
(range: 5–1296 days) after OLT. On univariate analysis the factors
significantly associated with biliary strictures were PL graft, HTK
preservation solution, ReY biliary anastomosis and HAS or HAT.
On multivariate analysis, the only factors independently associ-
ated with biliary stricture were PL graft, ReY anastomosis and
paediatric status (Table 2).
A subgroup analysis was carried out for all adult recipients
of WL grafts (n = 289) to further minimize any bias created
by strong predictors such as paediatric status and PL graft. This
demonstrated HTK preservation solution and an ReY biliary
anastomosis to be independent risk factors for the occurrence of
biliary strictures (Table 3).
Twenty-five (40%) patients with biliary strictures were success-
fully managed by endoscopic or radiological dilatation and stent-
ing. Thirteen of these were managed by endoscopy and stenting
alone, with a median of three (range: 1–8) endoscopic stent
insertion/exchange procedures. The median time to stricture
resolution was 61 days (range: 36–118 days). The remaining
12 patients underwent radiology-guided percutaneous stent
insertion or combined ERCP and percutaneous treatment.
In one patient, the stricture was associated with late HAS and
required concomitant hepatic artery stenting. The median time to
complete resolution with percutaneous stenting was 109 days
(range: 74–236 days), during which a median of four (range: 2–9)
interventions were carried out.
Thirty-eight (60%) patients in whom strictures did not
respond to non-surgical treatment underwent surgical revision.
Of these, 31 underwent biliary reconstruction with an ReY hepati-
cojejunostomy. The overall success rate of post-stricture ReY
biliary reconstruction was 87% (27/31). The four patients who
developed recurrent strictures after biliary reconstruction were
treated with PTC dilatation and stenting (n = 2), surgical
re-revision (n = 1) and retransplantation (n = 1). Four patients
with severe ischaemic cholangiopathy secondary to HAS or
HAT were not suitable for reconstruction. Three were successfully
retransplanted, but the fourth exhibited an unrelated malignancy
Table 1 Demographic information
Variable/characteristics n %
Patient characteristics
Age (median = 43 years; range: 5 months to 69 years)
Paediatric, <14 years 39 11
Adult, 14 years 309 89
Gender
Male 190 55
Female 158 45
Aetiology of liver disease
Fulminant 26 7
Primary sclerosing cholangitis 24 7
Primary biliary cirrhosis 13 4
Hepatitis B 67 19
Hepatitis C 76 22
Cryptogenic 31 9
Alcohol-related 29 8
Autoimmune 8 2
Budd–Chiari syndrome 11 3
Biliary atresia/Alagille syndrome 27 8
Retransplants 10 3
Hepatic artery thrombosis/primary non-function 6 2
Other 20 6
Donor characteristics
Age (median = 40 years; range: 5–79 years)
Age <50 years 235 68
Age 50 years 113 32
Gender
Male 184 53
Female 164 47
Transplant characteristics
Warm ischaemia (median = 8 min; range: 28–69 min)
<45 min 239 69
45 min 109 31
Cold ischaemia (median = 439 min; range: 106–916 min)
<10 h 226 65
10 h 112 35
Graft size
Whole liver 296 85
Split-liver graft 24 7
Reduced-size graft 8 2
Live-donor graft 20 6
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and was not considered for retransplantation. Three patients with
segmental NAS were managed with segmental liver resections.
Discussion
This study represents a complete audit of biliary complications in
348 consecutive OLTs performed at the NZLTU over a 10-year
period. The overall rate of biliary complications was 20% and
rates of occurrence of strictures and bile leaks were 18% and 5%,
respectively. Most patients with anastomotic bile leaks went on to
develop subsequent AS (Fig. 3). Overall, 40% of the strictures
were successfully managed by non-operative interventions and
60% eventually required surgical correction. Four patients under-
went retransplantation, but no mortality directly related to biliary
complications occurred.
The reported incidence of post-transplant biliary strictures
varies widely among different study groups depending on the
extent of follow-up and the nature of the study population. In
deceased-donor transplants, the reported incidence is 5–15%,2,4
whereas in living-donor transplants it may be as high as 32%.5–7
The incidence in the present study, which included all transplant
types, falls within this range. Similarly, the incidence of bile l eaks
is within the reported range of 2–15%.2,8,9
Many factors have been reported to be associated with the
occurrence of post-transplant biliary strictures. These include
paediatric status,10 recurrent PSC,11 advanced donor age,12,13
donation after cardiac death,14,15 prolonged WIT and CIT,16,17
ABO incompatibility,18,19 type of biliary reconstruction,20,21 HAS
or HAT,22,23 postoperative bile leak,24,25 severe rejection,26 and
cytomegalovirus (CMV) infection.27 Interestingly, donor age,
WIT and CIT were not found to be independently associated
with biliary strictures in our study. The allograft bile ducts
are perfused exclusively from the hepatic arterial blood supply.
Therefore, any compromise in the hepatic artery will result in
bile duct ischaemia, leading to stricture formation. Six of 16
(38%) recipients of transplants that were complicated by HAS
or HAT in our series went on to develop bile duct strictures.
Although HAS/HAT was not found to be an independent risk
factor for biliary strictures in the statistical analysis, three of the
four patients who required retransplantation had concomitant
arterial problems.
The higher incidence of biliary problems among recipients of
PL grafts is related to the small calibre of the ducts and the poten-
tial for the compromise of the periductal vascular supply during
the preparation of such grafts.28,29 Leaks from small unrecognized
tributaries or the cut surface may also contribute. An ReY biliary
Bile leaks (n = 17)
Anastomotic leaks
(n = 11)
Cut surface leaks
(n = 4)
Cystic duct stump 
leaks (n = 2)
ERCP + stenting
Percutaneous drainage
(n = 2)
Surgical 
repair
(n = 2) Surgical 
repair
(n = 5) 
ERCP + 
stenting 
(n = 6) 
Progression to AS 
(n = 10)
(n = 6) (n = 4)
Treated as AS
Figure 1 Outcome of post-transplant bile leaks. ERCP, endoscopic retrograde cholangiopancreatography; AS, anastomotic stricture
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anastomosis was found to be an independent risk factor for
stricture formation, even when paediatric recipients and PL grafts
were excluded (Table 2). Bacterial colonization of the biliary tree
originating from the choledochojejunal anastomosis may account
for the increased risk associated with an ReY.
The ischaemic-type biliary lesion (ITBL) (Fig. 4) refers to cho-
langiopathy that occurs in the absence of a recognized cause, such
as HAS/HAT, recurrent PSC or chronic ductopaenic rejection.30,31
Reported incidences of ITBL vary widely among transplant
centres and range from as little as 1.4% to as much as 26.0%.13,32–34
This inconsistency probably reflects a lack of consensus on the
definition of ITBL as the term is sometimes used to describe all
NAS. Although the aetiology of ITBL is multifactorial, one of the
mechanisms strongly implicated is ischaemic injury to the biliary
tree during organ procurement and preservation.16,35 In this
study, we attempted to identify any possible association of organ
preservation method with the incidence of ITBL.
The biliary epithelium is supplied solely from the hepatic
artery via small end-arteries and is therefore vulnerable to
incomplete perfusion during flushing with preservation fluid.
University of Wisconsin perfusion fluid has high viscosity at the
low temperatures used for organ preservation, and is theoreti-
Successful resolution
 (n = 25) (15 AS,  
7 AS+NAS, 3 NAS)
Recurrent stricture
(n = 38) (31 AS, 6 NAS, 1 AS+NAS)
Segmental liver resection 
(n = 3) (NAS)
Considered for re-transplant
(n = 4) (3 NAS, 1 AS+NAS)
Successfully re-transplanted 
(n = 3) (NAS)
Palliative care
(n = 1) (AS+NAS)
Surgical biliary reconstruction
(n = 31) (AS)
Successful resolution
(n = 27)
Recurrent stricture
(n = 4)
Successfully re-transplanted (n = 1) 
Second round of PTC dilatation and stenting (n = 2)
ERCP/PTC balloon dilatation /stenting (n = 62)
Open surgical access tube insertion (n = 1)
Biliary strictures
(n = 63) (46 AS, 8 AS+NAS, 9 NAS)
Second surgical reconstruction (n = 1) 
Figure 2 Outcome of post-transplant biliary strictures. AS, anastomotic stricture; NAS, non-anastomotic stricture; ERCP, endoscopic
retrograde cholangiopancreatography; PTC, percutaneous transhepatic cholangiography
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cally disadvantageous in this regard. Others have reported that
hepatic APP with UWS reduces the risk for ITBL.13 An alterna-
tive strategy is to use low-viscosity perfusion solutions such as
HTK.32 We used both of these methods during the study period
and, interestingly, found that HTK was associated with an
increased rate of biliary strictures among adult recipients with
WL grafts. We conducted separate comparisons for AS and NAS,
but found no clear association of perfusion technique or solu-
tion with purely NAS. When the patient with concomitant HAS
and NAS was excluded, only eight cases of ITBL were identified
in total; these included three of 128 (2%) patients in whom
UWS standard perfusion had been performed, five of 174 (3%)
patients who received UWS + APP, and no HTK patients. Hence,
the small number of ITBLs encountered may limit our ability to
draw any conclusions regarding the effect of preservation tech-
nique on ITBL. Nevertheless, a recent large study using registry
data found that HTK was associated with worse graft and patient
survival in liver transplantation, including live donor transplan-
tation.36 Based on these findings, as well as our own experience,
we have changed our practice again and returned to using UWS
as the preferred preservation solution.
One of the limitations of the present study is the retrospective
nature of its data analysis despite our access to a comprehensive
prospective database. In addition, as discussed earlier, changes in
graft type and perfusion technique occurred over the study
period. Further, the aetiology of the liver disease leading to OLT
was not considered in the analysis. Additional donor characteris-
tics (other than age), such as extended criteria donation, were not
considered separately because of the difficulties of retrieving such
data in a retrospective manner. The small sample size of ITBL and
HAT cases probably limits our ability to make definite recommen-
dations based on this study. However, as the NZLTU is the only
liver transplant unit in New Zealand, our study population was
all-inclusive and longterm follow-up data were available for all
patients. We also included all biliary problems regardless of other
factors such as vascular pathology. The findings are therefore
Table 2 Univariate and multivariate analysis for the presence of biliary strictures in all transplant recipients (n = 348)
Variables Total
transplants, n
Biliary
strictures,
n (%)
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Recipient age 0.79 (0.37–1.85) 0.57 5.10 (1.40–18.56) 0.014
<14 years 39 9 (23)
14 years 309 54 (17.5)
Donor age 1.08 (0.61–1.91) 0.79 1.24 (0.68–2.29) 0.48
50 years 113 22 (19.5)
<50 years 235 41 (17.4)
Graft 2.59 (1.34–5.01) 0.0046 3.10 (1.11–8.69) 0.031
Partial liver 52 16 (30.8)
Whole liver 296 47 (15.9)
Cold ischaemia time 1.11 (0.63–1.93) 0.73 1.34 (0.72–2.50) 0.36
10 h 122 23 (18.9)
<10 h 226 40 (17.7)
Warm ischaemia time 1.49 (0.81–2.02) 0.39 1.71 (0.96–2.37) 0.15
45 min 109 21 (19.3)
<45 min 239 42 (17.6)
Preservation
UWS 128 17 (13.3)
UWS + APP 174 33 (19.0) 1.53 (0.82–2.94) 0.19 1.65 (0.82–3.33) 0.17
HTK 46 13 (28.2) 3.16 (1.42–7.03) 0.0048 2.34 (0.93–5.88) 0.07
Biliary anastomosis 2.66 (1.48–4.79) 0.0011 3.28 (1.54–6.99) 0.002
Roux-en-Y 75 23 (30.7)
D–D 273 40 (14.7)
Hepatic artery disease 3.50 (1.17–10.46) 0.025 2.76 (0.84–9.11) 0.095
HAS/HAT+ 16 06 (37.5)
HAS/HAT- 332 57 (17.2)
OR, odds ratio; 95% CI, 95% confidence interval; UWS, University of Wisconsin perfusion fluid; APP, arterial pressure perfusion; HTK, histidine
tryptophan ketaglutarate infusion; D–D, duct-to-duct choledocho-choledochostomy; HAS, hepatic artery stenosis; HAT, hepatic artery thrombosis
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inclusive and representative of a real-world experience and are not
subject to incomplete follow-up or selection bias.
In conclusion, post-transplant biliary complications remain a
major cause of morbidity following OLT, affecting one in five
patients. Initial endoscopic or percutaneous management
was successful in 40% of patients, whereas surgical treatment
was required in 60%. Retransplantation was rarely required
in the absence of concomitant arterial pathology and no
mortality occurred as a direct result of biliary complications.
Table 3 Univariate and multivariate analysis for the presence of biliary strictures in whole graft adult recipients (n = 289)
Variables Univariate analysis Multivariate analysis
Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Donor age
50 years, <50 years 0.95 0.50–1.82 0.89 0.94 0.48–1.85 0.87
Cold ischaemia time
10 h, <10 h 1.14 0.60–2.15 0.69 1.35 0.68–2.71 0.40
Warm ischaemia time
45 min, <45 min 1.55 0.87–2.12 0.30 1.67 0.88–2.30 0.11
Preservation
UWS vs. APP 1.23 0.62–2.43 0.56 1.58 0.75–3.33 0.23
UWS vs. HTK 2.70 1.06–6.86 0.04 2.86 1.04–7.89 0.04
Biliary anastomosis
ReY, D–D 3.89 1.79–8.47 0.0006 3.89 1.73–8.74 0.001
Hepatic artery disease
HAS/HAT+ 3.04 0.853–10.821 0.086 2.88 0.75–11.09 0.12
HAS/HAT-
95% CI, 95% confidence interval; UWS, University of Wisconsin perfusion fluid; APP, arterial pressure perfusion; HTK, histidine trypto-
phan ketaglutarate infusion; ReY, Roux-en-Y; D–D, duct-to-duct choledocho-choledochostomy; HAS, hepatic artery stenosis; HAT, hepatic artery
thrombosis
Figure 3 Anastomotic biliary stricture (WL transplant presenting at
post-operative day 37)
Figure 4 Non-anastomotic biliary strictures complicating an
anastomotic stricture (WL transplant presenting at post-operative
day 51)
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